Prediction of functional recovery and prognosis in patients with acute myocardial infarction by 123I-BMIPP and 201Tl myocardial single photon emission computed tomography: A multicenter trial

Annals of Nuclear Medicine

Volumn 12, Issue 5, 1998, Pages 237-248

  Nishimura, Tsunehiko ^a   Nishimura, Shigeyuki ^b   Kajiya, Teishi ^c   Sugihara, Hiroki ^d   Kitahara, Kouichi ^e   Imai, Kamon ^f   Muramatsu, Toshiya ^g   Takahashi, Nobukazu ^h   Yoshida, Hiroshi ⁱ   Osada, Takanori ^j   Terada, Kouji ^k   Ito, Tatsuo ^l   Naruse, Hitoshi ^m   Iwabuchi, Masashi ⁿ  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b YOKOHAMA ROSAI HOSPITAL   (Japan)

^c Himeji Cardiovascular Center   (Japan)

^d KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^e SAKAKIBARA HEART INSTITUTE   (Japan)

^f Saitama Ohara Cardiovascular Center   (Japan)

^g KAWASAKI MUNICIPAL HOSPITAL   (Japan)

^h YOKOHAMA CITY UNIVERSITY HOSPITAL   (Japan)

ⁱ SHIZUOKA GENERAL HOSPITAL   (Japan)

^j Department of General Surgery Kofu Kyoritsu Hospital   (Japan)

^k Murakami Memorial Hospital   (Japan)

^l OSAKA ROSAI HOSPITAL   (Japan)

^m HYOGO COLLEGE OF MEDICINE   (Japan)

ⁿ Fukuyama Cardiovascular Hospital   (Japan)

more..

Author keywords

123I BMIPP; Acute myocardial infarction; Prognosis; Single photon emission computed tomography; Ventricular function

Indexed keywords

15 (4 IODOPHENYL)PENTADECANOIC ACID I 123;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CLINICAL TRIAL; DIAGNOSTIC VALUE; FEMALE; HEART DEATH; HEART EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART VENTRICLE FUNCTION; HEART VENTRICULOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ONSET AGE; PRIORITY JOURNAL; PROBABILITY; PROGNOSIS; RADIOISOTOPE DISTRIBUTION; RECURRENT DISEASE; REGRESSION ANALYSIS; RISK ASSESSMENT; SEX RATIO; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 18244410726     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03164908     Document Type: Article

References (41)

1. Brown KA. Prognostic value of thallium-201 myocardial perfusion imaging: a diagnostic tool comes of age. Circulation 83: 363-381, 1991.
2. Gibson RS, Watson DD, Graddock GB, Crampton RS, Kaiser DL, Denny MJ, et al. Prediction of cardiac events after uncomplicated myocardial infarction: a prospective study comparing predischarge exercise thallium-201 scintigraphy and coronary angiography. Circulation 68: 321-336, 1983.
3. Brown KA, O'Meara J, Chambers CE, Plante DA. Ability of dipyridamole-thallium-201 imaging 1 to 4 days after acute myocardial infarction to predict in-hospital and late recurrent myocardial ischemic events. Am J Cardiol 65: 160-167, 1990.
4. Brown KA, Weiss RM, Clements JP, Wackers FJ Th. Usefulness of residual ischemic myocardium within prior infarct zone for identifying patients at high risk late after acute myocardial infarction. Am J Cardiol 60: 15-19, 1987.
5. The Multicenter Post Infarction Research Group. Risk stratification and survival after myocardial infarction. N Engl J Med 309: 331-336, 1983.
6. Cerqueira MD, Maynard C, Ritchie JL, Davis KB, Kennedy JW. Long-term survival in 618 patients from the Western Washington streptokinase in myocardial infarction trials. J Am Coll Cardiol 20: 1452-1459, 1992.
7. Simoons ML, Vos J, Tijssen JGP, Vermeer F, Verheugt FWA, Krauss XH, et al. Long-term benefit of early thrombolytic therapy in patients with acute myocardial infarction: 5 year follow-up of a trial conducted by the interuniversity cardiology institute of the Netherlands. J Am Coll Cardiol 14: 1609-1615, 1989.
8. Zaret BL, Wackers FJ Th, Terrin ML, Forman SA, Williams DO, Knatterud GL, et al. Value of radionuclide rest and exercise left ventricular ejection fraction in assessing survival of patients after thrombolytic therapy for acute myocardial infarction: results of thrombolysis in myocardial infarction (TIMI) Phase II study. J Am Coll Cardiol 26: 73-79, 1995.
9. Sobel BE. Coronary thrombolysis and the new biology. J Am Coll Cardiol 14: 850-860, 1989.
10. Moss AJ, Goldstein RE, Hall WJ, Bigger JT, Fleiss JL, Greenberg H, et al. Detection and significance of myocardial ischemia in stable patients after recovery from an acute coronary event. Multicenter myocardial ischemia research group. JAMA 269: 2379-2385, 1993.
11. Miller TD, Gersh BJ, Christian TF, Bailey KR, Gibbons RJ. Limited prognostic value of thallium-201 exercise treadmill testing early after myocardial infarction in patients treated with thrombolysis. Am Heart J 130: 259-266, 1995.
12. 201 T1 tomography in patients treated with thrombolytic therapy during acute myocardial infarction. Circulation 94: 2735-2742, 1996.
13. Eitzman D, Al-Aouar Z, Kanter HL, vom Dahl J, Kirsh M, Deeb GM, et al. Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography. J Am Coll Cardiol 20: 559-565, 1992.
14. Tamaki N, Kawamoto M, Takahashi N, Yonekura Y, Magata Y, Nohara R, et al. Prognostic value of an increase in fluorine-18 deoxyglucose uptake in patients with myocardial infarction: Comparison with stress thallium imaging. J Am Coll Cardiol 22: 1621-1627, 1993.
15. Di Carli MF, Davidson M, Little R, Khanna S, Mody FV, Brunken RC, et al. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol 73: 527-533, 1994.
16. Knapp FF Jr, Kropp J. Iodine-123-labelled fatty acids for myocardial single photon emission tomography: current status and future perspective. Eur J Nucl Med 22: 361-381, 1995.
17. Yamamichi Y, Kusuoka H, Morishita K, Shirakami Y, Kurami M, Okano K, et al. Metabolism of iodine-123-BMIPP in perfused rat hearts. J Nucl Med 36: 1043-1050, 1995.
18. Nishimura T. Current status of nuclear cardiology in Japan. J Nucl Cardiol 3: 422-427, 1996.
19. Hashimoto A, Nakata T, Tsuchihashi K, Tanaka S, Fujimori K, Iimura O. Post ischemic functional recovery and BMIPP uptake after primary percutaneous transluminal coronary angioplasty in acute myocardial infarction. Am J Cardiol 77: 25-30, 1996.
20. 201 TI SPET images. Eur J Nucl Med 23: 917-923, 1996.
21. 123I) iodophenyl pentadecanoic acid, single photon emission computed tomography in cardiac disease. J Nucl Cardiol 1: S65-S71, 1994.
22. Tamaki N, Kawamoto M. The use of iodinated free fatty acids for assessing fatty acid metabolism. J Nucl Cardiol 1: S72-S78, 1994.
23. Subcommittee for standardization of radionuclide imaging, medical and pharmaceutical committee, Japan Radioisotope Association. Standard of nuclear medicine protocols (The 3rd revision, 1994). Radioisotopes 43: 81-114, 1994.
24. Rentrop KP, Cohen M, Blanke H, Phillips RA. Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol 5: 587-592, 1985.
25. Cox DR. Regression models and life-tables (with discussion). J Royal Stat Soc Series B 34: 187-220, 1972.
26. Cary, North Carolina: SAS Institute Inc. SAS Technical Report P-229, SAS/STAT software: Changes and Enhancement, release 6.07 edition, 620 p, 1992.
27. Cary, North Carolina: SAS Institute Inc. SAS/STAT User's Guide, release 6.03 edition, 1028 p, 1988.
28. The TIMI study group. The thrombolysis in myocardial infarction (TIMI) trial. Phase I findings. N Engl J Med 312: 932-936, 1985.
29. Fujibayashi Y, Yonekura Y, Takemura Y, Wada K, Matsumoto K, Tamaki N, et al. Myocardial accumulation of iodinated beta-methyl-branched fatty acid analogue, iodine-125-15-(p-iodophenyl)-3-(R,S)methylpentadecanoic acid (BMIPP), in relation to ATP concentration. J Nucl Med 31: 1818-1822, 1990.
30. Ogata M, Kajiyama K, Yamaguchi Y, Koga Y, Toshima H. BMIPP uptake in adriamycin cardiomyopathic rat hearts. J Mol Cell Cardiol 20: 28-32, 1988.
31. Tamaki N, Kawamoto M, Yonekura Y, Fujibayashi Y, Takahashi N, Konishi J, et al. Regional metabolic abnormality in relation to perfusion and wall motion in patients with myocardial infarction: assessment with emission tomography using an iodinated branched fatty acid analog, J Nucl Med 33: 659-667, 1992.
32. 123I-β-methyl-iodo-phenyl pentadecanoic acid. Eur J Nucl Med 21: 283-291, 1994.
33. Franken PR. De Geeter F, Dendale P, Demoor D, Block P, Bossuyt A. Abnormal free fatty acid uptake in subacute myocardial infarction after coronary thrombolysis: correlation with wall motion and inotropic reserve. J Nucl Med 35: 1758-1765, 1994.
34. Tamaki N, Tadamura E, Kudoh T, Hattori N, Yonekura Y, Nohara R, et al. Prognostic value of iodine-123 labelled BMIPP fatty acid analogue imaging in patients with myocardial infarction. Eur J Nucl Med 23: 272-279, 1996.
35. Moss AJ, Benhorin J. Prognosis and management after a first myocardial infarction. N Engl J Med 307: 743-753, 1990.
36. Ito H, Tomooka T, Sakai N, Higashino Y, Fujii K, Katoh O, et al. Time course of functional improvement in stunned myocardium in risk area in patients with reperfuscd anterior infarction. Circulation 87: 355-362, 1993.
37. Picard MH, Wilkins GT, Ray P, Weyman AE. Long-term effects of acute thrombolystic therapy on ventricular size and function. Am Heart J 126: 1-10, 1993.
38. Bolli R. Myocardial 'stunning' in man. Circulation 86: 1671-1691, 1992.
39. Pfisterer M, Zuber M, Wenzel R, Burkart F. Prolonged myocardial stunning after thrombolysis: can left ventricular function be assessed definitely at hospital discharge? Eur Heart J 12: 214-217, 1991.
40. Schwaiger M, Bunken R, Grover-McKay M, Krivokapich J, Child J, Tillisch JH, et al. Regional myocardial metabolism in patients with acute myocardial infarction assessed by positron emission tomography. J Am Coll Cardiol 8: 800-808, 1986.
41. Franken PR, Dendale P, De Greeter F, Demoor D, Bossuyt A, Block P. Prediction of functional outcome after myocardial infarction using BMIPP and sestamibi scintigraphy. J Nucl Med 37: 718-722, 1996.